PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 12435290-5 2002 It was shown that the addition of sequential docetaxel (100 mg/m2) to CVAP neoadjuvant chemotherapy resulted in a significantly enhanced clinical response rate (94% vs. 64%) and a substantially increased complete histopathological response rate (34% vs. 16%) when compared to patients receiving CVAP alone. Docetaxel 45-54 amyloid beta precursor protein Homo sapiens 295-299